Merck and Chengdu East New Area Management Committee signed a cooperation agreement at the CIIE

Merck's high-quality end-to-end solution will solidify the construction of the life science technology transformation platform in Chengdu, the Western Economic and Innovation Center

Merck is also actively promoting progress in life science related fields such as in vitro diagnostics

Shanghai China,2024year11moon6day——Merck11moon6The China International Import Expo（CIIESigned a non binding cooperation agreement with the Chengdu East New Area Management Committee at the CIIE booth. Both sides hope to work together to establish a life science and technology transformation platform in Chengdu, the fourth largest city in China in terms of population. Chengdu is also known as the cultural, economic, and innovation center of western China.

Dr. Wu Bo, Vice President of Merck Life Sciences and Managing Director of Life Sciences China, stated that

The CIIE platform provides valuable opportunities for us to achieve closer cooperation with customers and meet their constantly changing needs. We look forward to working together with the government of Chengdu East New Area to promote the steady development of the local life science industry and related fields.

According to the agreement, Merck will provide“High tech, efficient, high-quality”（“New Quality Productivity”The characteristics of the product and service will help strengthen the service capabilities of the Chengdu East New Area Life Science and Technology Transformation Platform.

Merck will focus on providing technical training, application demonstrations, operational support, and other support for the platform in areas such as biopharmaceuticals, and enhance the development of the Chengdu East New Area“Future Medical City”The investment attractiveness of the project.

Merck's CIIE booth also highlights its capabilities in innovation and providing products and customized services. These products and services not only cover biopharmaceuticals, but also“radiation”To adjacent industries such as in vitro diagnostics, as well as related fields such as new energy and electronic technology.

Over the past year, Merck's life sciences business in China has strengthened its support for local in vitro diagnostic kit manufacturing. According to the World Health Organization, China is one of the countries with the fastest aging population growth in the world. The demand for in vitro diagnostic products in the Chinese market is expected to grow.

Merck continues to strengthen its use of digital technology to promote technological progress. Merck can provide a wide product portfolio covering the entire life science industry chain——From research and development to process development and scaling up, to biosafety testing and commercial production, Merck's end-to-end solutions and services aim to fully support the healthy development of upstream and downstream companies in the industry. In addition, Merck also integrates sustainable development concepts into local operations and actively helps customers achieve efficient and sustainable long-term business development.

As a strategic measure to further open up the Chinese market to the world, promote trade and economic globalization, the CIIE2018It will be held once a year from now on.